跳到正文
原文
HHS· @HHSGov · X·· 15 天前精选AI 评分58
AI 导读

美国卫生与公众服务部(HHS)宣布,FDA 已批准更新另外三款绝经激素治疗产品的标签。HHS 表示,这些更新使标签更贴近当前科学认知,帮助女性和其医疗专业人员根据个人需求、获益与风险做出知情决策。数十年来,黑框警告一直影响着围绕激素治疗的讨论。

推荐理由

FDA 更新绝经激素治疗产品标签,读者可了解黑框警告与当前科学认知之间的调整方向。

正文

🚨 A major step forward for women’s health: The FDA has approved updated labeling for three more menopause hormone therapy products.

For decades, black box warnings shaped conversations about hormone therapy. These updates bring labeling closer to current science and help women and their health care professionals make informed decisions based on individual needs, benefits, and risks.

Under @POTUS and @SecKennedy's leadership, HHS and @FDA are putting women’s health first — advancing gold standard science, improving access, and helping women get the care that’s right for them.

来源:HHS · x.com